GR75495B - - Google Patents
Info
- Publication number
- GR75495B GR75495B GR68138A GR820168138A GR75495B GR 75495 B GR75495 B GR 75495B GR 68138 A GR68138 A GR 68138A GR 820168138 A GR820168138 A GR 820168138A GR 75495 B GR75495 B GR 75495B
- Authority
- GR
- Greece
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56073293A JPS57188526A (en) | 1981-05-14 | 1981-05-14 | Peptide-containing pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
GR75495B true GR75495B (el) | 1984-07-24 |
Family
ID=13513959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR68138A GR75495B (el) | 1981-05-14 | 1982-05-13 |
Country Status (9)
Country | Link |
---|---|
US (1) | US4504470A (el) |
EP (1) | EP0067513B1 (el) |
JP (1) | JPS57188526A (el) |
KR (1) | KR880001983B1 (el) |
CA (1) | CA1165245A (el) |
DE (1) | DE3276743D1 (el) |
ES (1) | ES8303086A1 (el) |
GR (1) | GR75495B (el) |
PT (1) | PT74891B (el) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0177342A3 (en) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Oral formulation of therapeutic proteins |
US5474980A (en) * | 1984-10-04 | 1995-12-12 | Monsanto Company | Prolonged release of biologically active somatotropins |
US5411951A (en) * | 1984-10-04 | 1995-05-02 | Monsanto Company | Prolonged release of biologically active somatotropin |
FR2585709B1 (fr) * | 1985-08-05 | 1987-10-02 | Adir | Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2526589B2 (ja) * | 1986-08-08 | 1996-08-21 | 武田薬品工業株式会社 | ペプチド含有マイクロカプセルおよびその製造法 |
US4897256A (en) * | 1986-11-25 | 1990-01-30 | Abbott Laboratories | LHRH analog formulations |
AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
JPS63316724A (ja) * | 1987-06-19 | 1988-12-26 | Nippon Shinyaku Co Ltd | 抗けいれん剤 |
DE3845000C2 (de) * | 1987-07-10 | 1998-11-19 | Novartis Ag | Anwendung von Octreotid zur Behandlung von Brustkrebs |
US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
JPH02104531A (ja) * | 1988-10-14 | 1990-04-17 | Toyo Jozo Co Ltd | 経鼻投与用生理活性ペプチド組成物 |
EP0432431B1 (en) * | 1989-11-16 | 1993-06-16 | PHIDEA S.p.A. | Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
US5270042A (en) * | 1993-02-23 | 1993-12-14 | Juanita Whitham | Medicinal salve composition |
US5424289A (en) * | 1993-07-30 | 1995-06-13 | Alza Corporation | Solid formulations of therapeutic proteins for gastrointestinal delivery |
CN1098708C (zh) * | 1993-10-21 | 2003-01-15 | 久光制药株式会社 | 经鼻吸收的组合物以及含有该组合物的经鼻吸收制剂 |
JP2000505425A (ja) * | 1996-02-05 | 2000-05-09 | イーライ・リリー・アンド・カンパニー | Trhを用いるベータ―アミロイドペプチドに関連する状態の処置方法 |
US20030017181A1 (en) | 2001-05-31 | 2003-01-23 | Rood Gloria A. | Dermatological compositions and methods |
US20030159702A1 (en) * | 2002-01-21 | 2003-08-28 | Lindell Katarina E.A. | Formulation and use manufacture thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS528375B2 (el) * | 1973-07-02 | 1977-03-09 | ||
JPS51118841A (en) * | 1975-04-03 | 1976-10-19 | Takeda Chem Ind Ltd | A drug for improving and treating clouding of consciousness |
DE2558858A1 (de) * | 1975-12-27 | 1977-07-14 | Hoechst Ag | Klebstoffgemisch |
US4211769A (en) * | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
US4181709A (en) * | 1977-09-02 | 1980-01-01 | Eastman Kodak Company | Rumen-stable pellets |
GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
JPS605570B2 (ja) * | 1979-10-06 | 1985-02-12 | 株式会社ジャ−ド | 崩壊剤の製造法 |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
JPS56138110A (en) * | 1980-03-28 | 1981-10-28 | Teijin Ltd | Suppository containing citric acid or salt thereof |
-
1981
- 1981-05-14 JP JP56073293A patent/JPS57188526A/ja active Granted
-
1982
- 1982-04-30 EP EP82302238A patent/EP0067513B1/en not_active Expired
- 1982-04-30 DE DE8282302238T patent/DE3276743D1/de not_active Expired
- 1982-05-12 CA CA000402836A patent/CA1165245A/en not_active Expired
- 1982-05-12 US US06/377,592 patent/US4504470A/en not_active Expired - Fee Related
- 1982-05-12 PT PT74891A patent/PT74891B/pt unknown
- 1982-05-13 ES ES512149A patent/ES8303086A1/es not_active Expired
- 1982-05-13 GR GR68138A patent/GR75495B/el unknown
- 1982-05-14 KR KR8202103A patent/KR880001983B1/ko active
Also Published As
Publication number | Publication date |
---|---|
CA1165245A (en) | 1984-04-10 |
KR880001983B1 (ko) | 1988-10-10 |
ES512149A0 (es) | 1983-02-01 |
DE3276743D1 (en) | 1987-08-20 |
JPH0222049B2 (el) | 1990-05-17 |
EP0067513B1 (en) | 1987-07-15 |
KR830009771A (ko) | 1983-12-23 |
PT74891A (en) | 1982-06-01 |
EP0067513A3 (en) | 1983-10-05 |
EP0067513A2 (en) | 1982-12-22 |
US4504470A (en) | 1985-03-12 |
JPS57188526A (en) | 1982-11-19 |
ES8303086A1 (es) | 1983-02-01 |
PT74891B (en) | 1983-12-23 |